DE60110247D1 - Angiogenische Tri- oder Tetrapeptide abgeleitet von AcSDKP - Google Patents

Angiogenische Tri- oder Tetrapeptide abgeleitet von AcSDKP

Info

Publication number
DE60110247D1
DE60110247D1 DE60110247T DE60110247T DE60110247D1 DE 60110247 D1 DE60110247 D1 DE 60110247D1 DE 60110247 T DE60110247 T DE 60110247T DE 60110247 T DE60110247 T DE 60110247T DE 60110247 D1 DE60110247 D1 DE 60110247D1
Authority
DE
Germany
Prior art keywords
acsdkp
angiogenic
tri
tetrapeptides
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60110247T
Other languages
English (en)
Other versions
DE60110247T2 (de
Inventor
Joanna Bakala
Jean-Paul Potier
Francoise Lawrence
Nathalie Cheviron
Jerome Bignon
Yves Fromes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of DE60110247D1 publication Critical patent/DE60110247D1/de
Publication of DE60110247T2 publication Critical patent/DE60110247T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE60110247T 2000-09-21 2001-09-20 Angiogenische Tri- oder Tetrapeptide abgeleitet von AcSDKP Expired - Lifetime DE60110247T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0012028 2000-09-21
FR0012028A FR2814076B1 (fr) 2000-09-21 2000-09-21 Agent angiogenique et ses utilisations
PCT/FR2001/002923 WO2002024218A1 (fr) 2000-09-21 2001-09-20 Agent angiogeniques et leurs utilisations

Publications (2)

Publication Number Publication Date
DE60110247D1 true DE60110247D1 (de) 2005-05-25
DE60110247T2 DE60110247T2 (de) 2006-03-09

Family

ID=8854526

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60110247T Expired - Lifetime DE60110247T2 (de) 2000-09-21 2001-09-20 Angiogenische Tri- oder Tetrapeptide abgeleitet von AcSDKP

Country Status (9)

Country Link
US (1) US7235532B2 (de)
EP (1) EP1318829B1 (de)
JP (1) JP4925551B2 (de)
AU (1) AU2001291962A1 (de)
CA (1) CA2423190C (de)
DE (1) DE60110247T2 (de)
ES (1) ES2240520T3 (de)
FR (1) FR2814076B1 (de)
WO (1) WO2002024218A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2872040B1 (fr) 2004-06-23 2006-09-22 Centre Nat Rech Scient Cnrse Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent antivieillissement et restructurant de la peau
FR2882256B1 (fr) * 2005-02-18 2007-05-25 Centre Nat Rech Scient Utilisation cosmetique d'au moins un tetrapeptide naturel ac-n-ser-asp-lys-pro- ou un de ses analogues en tant qu'agent pour ralentir la chute des cheveux et/ou stimuler leur croissance
KR101335203B1 (ko) * 2010-03-26 2013-11-29 숙명여자대학교산학협력단 혈관신생촉진용 펩타이드 및 이의 용도
EP2407478A1 (de) 2010-07-14 2012-01-18 GENETADI Biotech, S.L. Neue Cyclotetrapeptide mit pro-angiogenen Eigenschaften
CN105324122B (zh) * 2013-06-14 2019-08-27 赫里克斯生物医疗公司 可用于治疗多种皮肤病的衍生自人类c-x-c趋化因子的四肽

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0563329T3 (da) * 1990-12-21 1998-12-07 Curative Tech Inc Angiogene peptider
DE4224509C2 (de) * 1992-07-24 1995-04-20 Ruhenstroth Bauer Gerhard Prof Wirkstoff zur Hemmung der Proliferationsrate von Leberzellen
CA2244673A1 (en) * 1996-02-01 1997-08-07 Josiane Thierry Peptide inhibitors of hematopoietic cell proliferation
AU766826B2 (en) * 1998-07-30 2003-10-23 Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The Thymosin beta4 promotes wound repair
US6815426B2 (en) * 2001-02-16 2004-11-09 E. I. Du Pont De Nemours And Company Angiogenesis-inhibitory tripeptides, compositions and their methods of use

Also Published As

Publication number Publication date
JP2004509148A (ja) 2004-03-25
JP4925551B2 (ja) 2012-04-25
CA2423190A1 (fr) 2002-03-28
AU2001291962A1 (en) 2002-04-02
ES2240520T3 (es) 2005-10-16
FR2814076B1 (fr) 2002-12-20
US20040038907A1 (en) 2004-02-26
FR2814076A1 (fr) 2002-03-22
EP1318829B1 (de) 2005-04-20
DE60110247T2 (de) 2006-03-09
US7235532B2 (en) 2007-06-26
CA2423190C (fr) 2011-06-07
EP1318829A1 (de) 2003-06-18
WO2002024218A1 (fr) 2002-03-28

Similar Documents

Publication Publication Date Title
ATE317854T1 (de) Hepatitis c inhibitor peptide
DK1042359T3 (da) k-Opioidreceptorpeptider
ATE437629T1 (de) Neue cyclosporin-analoge mikroemulsionsvorkonzentrate
DK2028186T3 (da) Hepatitis C inhibitor tri-peptider
NO982097L (no) Peptider
NO20031978L (no) Peptider som er MetAP-2 inhibitorer
FR14C0007I2 (fr) Remodelage et glycoconjugaison de peptides
DE60113894D1 (de) Dichtungsanordnungen
ATE449789T1 (de) Pacap-peptidanaloga
DE60102160D1 (de) Von arylalkylaminen abgeleitete carbamate
DE60014298D1 (de) Verbesserte Dichtungsanordnungen
DE60113903D1 (de) Lippenabdichtung
FR2798993B1 (fr) Gyrometre de type diapason
DE60327407D1 (de) Immunmodulierende peptide
DE60112496D1 (de) Lippendichtung
DE60125536D1 (de) Anordnung zur generierung von elementensequenzen
DE60122873D1 (de) Therapeutische porenbildende peptide
DE69931382D1 (de) Intein vermittelte peptidligation
FR2813080B1 (fr) Peptides anti-heparine
DE60110247D1 (de) Angiogenische Tri- oder Tetrapeptide abgeleitet von AcSDKP
DE60034531D1 (de) Geneigte Schubdüse
NO20025817D0 (no) Oligopeptider
DE50009946D1 (de) Schädlingsbekämpfungsmittel/depsipeptide
DE50010600D1 (de) Dichtungsanordnung
FR2791348B1 (fr) POLYPEPTIDE Npt2B

Legal Events

Date Code Title Description
8364 No opposition during term of opposition